Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Matuszewski

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 6, 2014
Stability studies on the newly discovered cyclic form of tRNA N(6)-threonylcarbamoyladenosine (ct(6)A)Michal Matuszewski, Elzbieta Sochacka
Chemical Communications (Cambridge, England)|June 29, 2017
Efficient conversion of N<sup>6</sup>-threonylcarbamoyladenosine (t<sup>6</sup>A) into a tRNA native hydantoin cyclic form (ct<sup>6</sup>A) performed at nucleoside and oligoribonucleotide levelsMichal Matuszewski, Katarzyna Debiec, Elzbieta Sochacka
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 23, 2019
Chemical Synthesis of Oligoribonucleotide (ASL of tRNA<sup>Lys</sup> T. brucei) Containing a Recently Discovered Cyclic Form of 2-Methylthio-N<sup>6</sup> -threonylcarbamoyladenosine (ms<sup>2</sup> ct<sup>6</sup> A)Katarzyna Debiec, Michal Matuszewski, Karolina Podskoczyj, et al.
IEEE Transactions on Neural Networks and Learning Systems|August 1, 2020
Reconstructing Quantum States With Quantum Reservoir NetworksSanjib Ghosh, Andrzej Opala, Michal Matuszewski, et al.
Urologia Internationalis|September 19, 2018
Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 PatientsWojciech Krajewski, Michal Matuszewski, Sławomir Poletajew, et al.
Nucleic Acids Research|December 4, 2016
A hydantoin isoform of cyclic N6-threonylcarbamoyladenosine (ct6A) is present in tRNAsMichal Matuszewski, Jakub Wojciechowski, Kenjyo Miyauchi, et al.
International Journal of Environmental Research and Public Health|November 11, 2022
Prognostic Performance of Cystatin C in COVID-19: A Systematic Review and Meta-AnalysisMichal Matuszewski, Yurii Reznikov, Michal Pruc, et al.
Annals of Agricultural and Environmental Medicine : AAEM|March 31, 2023
Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients - a systematic review and meta-analysisMichal Matuszewski, Jerzy Ładny, Zubaid Rafique, et al.
Journal of Clinical Medicine|November 11, 2022
Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-AnalysisMichal Matuszewski, Lukasz Szarpak, Zubaid Rafique, et al.
The American Journal of Emergency Medicine|May 7, 2023
Comparison of the bébé VieScope™ and direct laryngoscope for pediatric tongue oedema scenario: A simulation studyPawel Wieczorek, Michal Pruc, Maciej Krajsman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|May 6, 2014
Stability studies on the newly discovered cyclic form of tRNA N(6)-threonylcarbamoyladenosine (ct(6)A)Michal Matuszewski, Elzbieta Sochacka
Chemical Communications (Cambridge, England)|June 29, 2017
Efficient conversion of N<sup>6</sup>-threonylcarbamoyladenosine (t<sup>6</sup>A) into a tRNA native hydantoin cyclic form (ct<sup>6</sup>A) performed at nucleoside and oligoribonucleotide levelsMichal Matuszewski, Katarzyna Debiec, Elzbieta Sochacka
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 23, 2019
Chemical Synthesis of Oligoribonucleotide (ASL of tRNA<sup>Lys</sup> T. brucei) Containing a Recently Discovered Cyclic Form of 2-Methylthio-N<sup>6</sup> -threonylcarbamoyladenosine (ms<sup>2</sup> ct<sup>6</sup> A)Katarzyna Debiec, Michal Matuszewski, Karolina Podskoczyj, et al.
IEEE Transactions on Neural Networks and Learning Systems|August 1, 2020
Reconstructing Quantum States With Quantum Reservoir NetworksSanjib Ghosh, Andrzej Opala, Michal Matuszewski, et al.
Urologia Internationalis|September 19, 2018
Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 PatientsWojciech Krajewski, Michal Matuszewski, Sławomir Poletajew, et al.
Nucleic Acids Research|December 4, 2016
A hydantoin isoform of cyclic N6-threonylcarbamoyladenosine (ct6A) is present in tRNAsMichal Matuszewski, Jakub Wojciechowski, Kenjyo Miyauchi, et al.
International Journal of Environmental Research and Public Health|November 11, 2022
Prognostic Performance of Cystatin C in COVID-19: A Systematic Review and Meta-AnalysisMichal Matuszewski, Yurii Reznikov, Michal Pruc, et al.
Annals of Agricultural and Environmental Medicine : AAEM|March 31, 2023
Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients - a systematic review and meta-analysisMichal Matuszewski, Jerzy Ładny, Zubaid Rafique, et al.
Journal of Clinical Medicine|November 11, 2022
Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-AnalysisMichal Matuszewski, Lukasz Szarpak, Zubaid Rafique, et al.
The American Journal of Emergency Medicine|May 7, 2023
Comparison of the bébé VieScope™ and direct laryngoscope for pediatric tongue oedema scenario: A simulation studyPawel Wieczorek, Michal Pruc, Maciej Krajsman, et al.
Pageof 2